Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas

被引：0
|
作者：
Francoise Bouet-Toussaint
Florian Cabillic
Olivier Toutirais
Matthieu Le Gallo
Cécile Thomas de la Pintière
Pascale Daniel
Noëlle Genetet
Bernard Meunier
Eric Dupont-Bierre
Karim Boudjema
Véronique Catros
机构：
[1] UPRES EA 3891,Laboratoire de Cytogénétique et Biologie Cellulaire
[2] Faculté de Médecine de Rennes,Département de Chirurgie Viscérale
[3] CHU de Rennes,undefined
[4] CHU de Rennes,undefined
来源：
Cancer Immunology, Immunotherapy | 2008年 / 57卷
关键词：
Human; T cells; Cytotoxic; Cell activation; Tumor immunity; T Cell receptors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：531 / 539
页数：8
相关论文
共 50 条
  • [21] The PPARα pathway in Vγ9Vδ2 T cell anergy
    Poupot, Mary
    Boissard, Frederic
    Betous, Delphine
    Bardouillet, Laure
    Fruchon, Severine
    L'Faqihi-Olive, Fatima
    Pont, Frederic
    Mekaouche, Mourad
    Ingoure, Sophie
    Sicard, Helene
    Dubreuilh, Guy
    Fournie, Jean-Jacques
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2014, 19 (04) : 649 - 658
  • [22] RELEASING THE RESTRAINTS OF Vγ9Vδ2 T-CELLS IN CANCER IMMUNOTHERAPY
    Ridgley, Laura
    Dalgleish, Angus
    Bodman-Smith, Mark
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A500 - A500
  • [23] Development and Selection of the Human Vγ9Vδ2+ T-Cell Repertoire
    Willcox, Carrie R.
    Davey, Martin S.
    Willcox, Benjamin E.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [24] Human Vγ9Vδ2 T cell expansion and their cytotoxic responses against cholangiocarcinoma
    Sawaisorn, Piamsiri
    Gaballa, Ahmed
    Saimuang, Kween
    Leepiyasakulchai, Chaniya
    Lertjuthaporn, Sakaorat
    Hongeng, Suradej
    Uhlin, Michael
    Jangpatarapongsa, Kulachart
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [25] Human Vγ9Vδ2 T cell expansion and their cytotoxic responses against cholangiocarcinoma
    Piamsiri Sawaisorn
    Ahmed Gaballa
    Kween Saimuang
    Chaniya Leepiyasakulchai
    Sakaorat Lertjuthaporn
    Suradej Hongeng
    Michael Uhlin
    Kulachart Jangpatarapongsa
    Scientific Reports, 14
  • [26] Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside
    Castella, Barbara
    Vitale, Candida
    Coscia, Marta
    Massaia, Massimo
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (14) : 2419 - 2432
  • [27] Development of V γ 9V δ 2T cell based chemo-immunotherapy in bladder cancer
    Shimizu, Teruki
    Tomogane, Mako
    Miyashita, Masatsugu
    Sano, Yusuke
    Shimizu, Daiki
    Ukimura, Osamu
    Ashihara, Eishi
    CANCER SCIENCE, 2018, 109 : 433 - 433
  • [28] Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside
    Barbara Castella
    Candida Vitale
    Marta Coscia
    Massimo Massaia
    Cellular and Molecular Life Sciences, 2011, 68 : 2419 - 2432
  • [29] Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity
    Stephen R. Mattarollo
    Tony Kenna
    Mie Nieda
    Andrew J. Nicol
    Cancer Immunology, Immunotherapy, 2007, 56 : 1285 - 1297
  • [30] Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity
    Mattarollo, Stephen R.
    Kenna, Tony
    Nieda, Mie
    Nicol, Andrew J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (08) : 1285 - 1297
12345